|
|
 |
|
Viewing report
|
|
|
|
Lymphoma Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., April 2010, Pages: 752
This report analyzes the worldwide markets for Lymphoma Therapeutics in US$ Million.
The report provides separate comprehensive analytics for US, Europe, and Rest of World.
Annual estimates and forecasts are provided for each region for the period 2006 through 2015.
The report profiles 93 companies including many key and niche players such as Allos Therapeutics, Inc., Astellas Pharma US, Inc., Biogen Idec, Biolex Therapeutics, Inc., Biovest International, Inc., Cell Therapeutics, Inc, Cephalon, Inc., Chugai Pharmaceutical Co., Ltd., Cyclacel Pharmaceuticals, Inc., Eisai, Ltd., EpiCept Corp., F. Hoffmann-la Roche Ltd., Genentech, Inc., Genmab, Genitope Corp., Genzyme Corporation, GlaxoSmithKline, Plc, Hana Biosciences, Inc., ImmunoGen, Inc., InNexus Biotechnology, Inc., and Millennium Pharmaceuticals, Inc.
Market data and analytics are derived from primary and secondary research.
Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying.
Customers who bought this item also bought
Anti-CD20 Monoclonal Antibodies - Global Strategic Business Report
Non-Hodgkin's Lymphoma (NHL) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Bladder Cancer Therapeutics - Global Strategic Business Report
Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015
Human Vaccines - Global Strategic Business Report
A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market
Glaucoma Pharmaceuticals - Global Strategic Business Report
Non-Hodgkin's Lymphoma (NHL) - Pipeline Assessment and Market Forecasts to 2017
Melanoma Therapeutics - Global Strategic Business Report
Neurodegenerative Drugs - Global Strategic Business Report
|
|
|
|
